Vancomycin Resistance in Gram-Positive Cocci—Old Bugs,New Tricks,Confusing Terminology

Flaherty J.P. , Weinstein R.A. Nosocomial infection caused by antibiotic-resistant organisms in the intensive care unit. Infect Control Hosp Epidemiol 1996; 17: 236–248.

Vincent J-L , Bihari D.J. , Suter P.M. . The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) study. JAMA 1995; 274: 639–644.

Pittet D. , Wenzel R.P. Nosocomial Bloodstream Infections: Secular trends in rates, mortality, and contribution to total hospital deaths. Arch Intern Med 1995; 155: 1177–1184.

Chambers H.E. Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications. Clin Micro Rev 1997; 10: 781–791.

Turnidge J.D. , Nimmo G.R. , Francis G. Evolution of resistance in Staphylococcus aureus in Australian teaching hospitals. Australian group on antimicrobial resistance. Med J Aust 1996; 164: 68–71.

Schaberg D.R. , Culver D.H. , Gaynes R.P. Major trends in the microbial etiology of nosocomial infection. Am J Med 1991; 91(Suppl 3B): 72S–75S.

CDC. Nosocomial enterococci resistant to vancomycin. MMWR 1993; 42: 597–599.

Murray B.E. The life and times of the enterococcus. Clin Micro Rev 1990; 3: 46–65.

Aarestrup F.M. Occurrence of glycopepetide resistance among Enteroccocus faecium isolates from conventional and ecological poultry farms. Microb Drug Resist 1995; 1: 255–257.

Noble W.C. , Virani Z. , Cree R.G. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol Lett 1992; 72: 195–198.

Michel M. , Gutmann L. Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: therapeutic realities and possibilities. Lancet 1997; 349: 1901–1906.

Murray B.E. Vancomycin-resistant enterococci. Am J Med 1997; 101: 284–293.

Bell J.M. , Paton J.C. , Turnidge J. Emergence of vancomycin-resistant enterococci in Australia: phenotypic and genotypic characteristics of isolates. J Clin Microbiol 1998; 36: 2187–2190.

Hiramatsu K. , Hanaki H. , Ino T. . Methicillin-resistant Staphylococcus aureus clinical strains with reduced vancomycin susceptibility. J Antimicrob Chemother 1997; 40: 135–136.

Hiramatsu K. , Aritaka N. , Hanaki H. . Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 1997; 350: 1670–1673.

CDC. Update: Staphylococcus aureus with reduced susceptibility to vancomycin—United States, 1997. MMWR 1997; 46: 813–814.

Kremery V. Jr. , Hanzen J. , Ciznar P. , Brezaniova T. Vancomycin-resistant Staphylococcus aureus in an immunocompromised child with Job's syndrome. Antibiotic Chemother 1997; 1: 6.

Leclercq R. , Courvalin P. Streptogramins: an answer to antibiotic resistance in gram-positive bacteria. Lancet 1998; 352: 591–592.

Tenover F.C. , Lancaster M.V. , Hill B.C. . Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides. J Clin Microbiol 1998; 36: 1020–1027.

CDC. Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR 1995; 44: 1–13.

CDC. Interim guidelines for prevention and control of staphylococcal infection associated with reduced susceptibility to vancomycin. MMWR 1997; 46: 626–635.

Goldmann D.A. , Weinstein R.A. , Wentzel R.P. . Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals. A challenge to hospital leadership. JAMA 1996; 275: 234–240.

Montecalvo M.A. , de Lencastre H. , Carraher M. . Natural history of colonization with vancomycin resistant Enterococcus faecium. Infect Control Hosp Epidemiol 1995; 16: 680–685.